Literature DB >> 7308986

Effect of chronic alcohol intake on hepatic fibrosis and granulomas in murine schistosomiasis mansoni.

H Orrego, Y Israel, I R Crossley, A A Mahmoud, P A Peters, G Varghese, I R Wanless.   

Abstract

In consideration of the vast prevalence of schistosomiasis and heavy alcohol consumption in many parts of the world, the possibility of an interaction between these two conditions inducing liver disease was studied in mice infected with Schistosoma mansoni. Alcohol consumption significantly reduced by 25% the mean granuloma diameter and by about 60% the extent of fibrous tissue deposition determined chemically as hydroxyproline. DNA, as an expression of the inflammatory and cellular components of the granulomatous reaction in the infected animals, was also significantly reduced by alcohol consumption. These results indicate the need for epidemiological studies in the clinical manifestations and course of schistosomiasis in human alcoholics.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308986     DOI: 10.1002/hep.1840010508

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  2 in total

1.  Does a combination of opisthorchiasis and ethyl alcohol consumption enhance early cholangiofibrosis, the risk of cholangiocarcinoma?

Authors:  Pranee Sriraj; Ratchadawan Aukkanimart; Thidarut Boonmars; Amornrat Juasook; Pakkayanee Sudsarn; Nadchanan Wonkchalee; Chawalit Pairojkul; Sakda Waraasawapati; Porntip Laummaunwai; Sirintip Boonjaraspinyo
Journal:  Parasitol Res       Date:  2013-06-27       Impact factor: 2.289

2.  Protective effect of some vitamins against the toxic action of ethanol on liver regeneration induced by partial hepatectomy in rats.

Authors:  Carlett Ramírez-Farías; Eduardo Madrigal-Santillán; José Gutiérrez-Salinas; Nidia Rodríguez-Sánchez; Maricela Martínez-Cruz; Ilse Valle-Jones; Ingrid Gramlich-Martínez; Alejandra Hernández-Ceruelos; José A Morales-Gonzaléz
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.